DEP-1 Antibodies

Santa Cruz Biotechnology provides a broad selection of DEP-1 monoclonal antibodies for research focused on understanding DEP-1's role in cellular processes. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DEP-1, also known as PTPRJ, is a protein tyrosine phosphatase that plays a critical role in regulating cell signaling pathways, particularly those involved in cell adhesion, migration, and proliferation. DEP-1 maintains cellular homeostasis and has significant implications in various diseases, including cancer and cardiovascular disorders. Research into DEP-1 mechanisms continues to reveal potential therapeutic targets and strategies for disease intervention. Scientists worldwide utilize DEP-1 monoclonal antibodies to advance their understanding of cell signaling pathways and their relationship to disease progression. Ongoing studies of DEP-1 contribute to the development of new therapeutic approaches in cancer research and cardiovascular medicine. Research laboratories can rely on Santa Cruz Biotechnology monoclonal antibodies to drive discoveries that benefit the scientific community and advance medical research.